The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.
E M Carvalho, R Badaró, S G Reed, T C Jones, W D Johnson Jr
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1973 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 2 | 1 | 1 | 3 | 2 | 1 | 5 | 3 | 8 | 4 | 7 | 7 | 6 | 12 | 7 | 6 | 5 | 9 | 9 | 10 | 6 | 6 | 5 | 5 | 9 | 12 | 5 | 3 | 5 | 11 | 19 | 11 | 10 | 7 | 7 | 8 | 8 | 3 | 2 | 1 | 253 |
Title and authors | Publication | Year |
---|---|---|
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant
Y Goto, LY Bogatzki, S Bertholet, RN Coler, SG Reed |
Vaccine | 2007 |
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis
LP Carvalho, S Passos, O Bacellar, M Lessa, RP Almeida, A Magalhães, WO Dutra, KJ Gollob, P Machado, AR de Jesus |
Parasite Immunology | 2007 |
Atypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10
B Rodriguez, R Beatty, A Belli, A Barreto, X Palacios, F Marin, E Harris |
Parasite Immunology | 2007 |
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2
S Bossolasco, S Nozza, G Gaiera, A Bestetti, A Lazzarin, P Cinque |
AIDS | 2007 |
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani
E McFarlane, C Perez, M Charmoy, C Allenbach, KC Carter, J Alexander, F Tacchini-Cottier |
Infection and immunity | 2007 |
Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains
T Baptista-Fernandes, C Marques, OR Rodrigues, GM Santos-Gomes |
Comparative Immunology Microbiology and Infectious Diseases | 2007 |
Immunopathology of Leishmaniasis: An Update
P Mansueto, G Vitale, GD Lorenzo, GB Rini, S Mansueto, E Cillari |
International journal of immunopathology and pharmacology | 2007 |
IL-10- and TGF-β-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India
S Saha, S Mondal, R Ravindran, S Bhowmick, D Modak, S Mallick, M Rahman, S Kar, R Goswami, SK Guha, N Pramanik, B Saha, N Ali |
Journal of immunology (Baltimore, Md. : 1950) | 2007 |
Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
RC Giunchetti, R Corrêa-Oliveira, OA Martins-Filho, A Teixeira-Carvalho, BM Roatt, RD de Oliveira Aguiar-Soares, JV de Souza, N das Dores Moreira, LC Malaquias, LL e Castro, M de Lana, AB Reis |
Vaccine | 2007 |